XORTX Therapeutics Inc
NASDAQ:XRTX
XORTX Therapeutics Inc
NASDAQ:XRTX
Price:
0.345
USD
-9.69%
Market Closed
Market Cap:
$1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
XORTX Therapeutics Inc
NASDAQ:XRTX
|
CA |
|
F
|
First Physicians Capital Group Inc
OTC:FPCG
|
US |
|
S
|
Shenzhen SC New Energy Technology Corp
SZSE:300724
|
CN |
|
M
|
Murray & Roberts Holdings Ltd
JSE:MUR
|
ZA |
|
Y
|
Yorkey Optical International (Cayman) Ltd
HKEX:2788
|
HK |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
M
|
Merck KGaA
MIL:MRK
|
DE |
|
D
|
Daaz Bara Lestari Tbk PT
IDX:DAAZ
|
ID |
Balance Sheet
Balance Sheet Decomposition
XORTX Therapeutics Inc
XORTX Therapeutics Inc
Balance Sheet Decomposition is not available for
XORTX Therapeutics Inc
XORTX Therapeutics Inc
Balance Sheet
XORTX Therapeutics Inc
XORTX Therapeutics Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
14
|
10
|
3
|
2
|
1
|
|
| Cash |
0
|
0
|
0
|
0
|
14
|
4
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
7
|
3
|
2
|
1
|
|
| Short-Term Investments |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
1
|
2
|
14
|
11
|
4
|
3
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+158%
|
1
-14%
|
2
+57%
|
15
+802%
|
12
-20%
|
5
-56%
|
4
-25%
|
3
-34%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
0
|
2
|
0
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
3
|
4
|
1
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-18%
|
1
+38%
|
1
-41%
|
4
+381%
|
5
+45%
|
1
-85%
|
1
-8%
|
1
-21%
|
|
| Equity | ||||||||||
| Common Stock |
1
|
6
|
6
|
6
|
14
|
17
|
17
|
19
|
20
|
|
| Retained Earnings |
2
|
6
|
7
|
6
|
2
|
9
|
12
|
15
|
18
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
1
|
1
|
1
|
5
|
6
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
12
+1 150%
|
7
-40%
|
5
-34%
|
3
-28%
|
2
-38%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+158%
|
1
-14%
|
2
+57%
|
15
+802%
|
12
-20%
|
5
-56%
|
4
-25%
|
3
-34%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
2
|
5
|
5
|
1
|
1
|
2
|
2
|
3
|
7
|
|
Switch to:
Switch to:
See Also
Discover More
